RBM39 and acne: Clinical cohorts with diverse acne severities and C. acnes phylotypes could enhance translational relevance, while CRISPR–based gene editing of HNRNPA2B1 or RBM39 in skin models could clarify their causal roles in inflammation and comedogenesis [32].